Novartis Stock Gains On European Drugmaker's Q1 Earnings Surprise, Lifts Annual OutlookBenzinga • 3 days ago
Discover Novartis' Q1 EPS soars 17% to $1.80, surpassing estimates. Sales hit $11.83B, up 10%. Entresto sales surge 36%, Cosentyx up 25%. CEO Vas Narasimhan bullish on mid & long-term growth.
read...
Share to Feed
Novartis CEO: Broadly Positive About Business Momentum...
Shares of Swiss drugmaker Novartis climbed 4.8% in early deals Tuesday after it raised its full-year guidance following better-than-expected first-quarter results...
Novartis Raises Guidance on Profit, Sales Growth...
Key Events This Week: PCE, GDP, Fed Blackout And Earnings Gallore
Hot on the heels of last week's tech and momentum rout, shaken traders will have to wait until Friday for the main...
It's been a busy week for Swiss healthcare giant Novartis. In a series of days, the company said it's slowing trials of its blockbuster cancer drug and slashing hundreds of jobs and attempting to...
Biotech Stocks Heat Up As Arvinas Scores Novartis Licensing Pact, Janux Reportedly Explores Options...
Futures On Edge Ahead Of Critical CPI Report
Futures are up small before the March CPI data was expected to show further moderation in price pressures following stronger readings at the...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...